CHICAGO—U.S. health officials are working to expand capabilities to test for monkeypox beyond a narrow group of public health labs, heeding calls from infectious disease experts who say testing for the virus needs to become part of routine care. Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky said during a conference call…
Existing Cancer Therapy Demonstrates Significant Effect Against Other Cancers: Study
June 12, 2022
admin
BrightcancerhealthHealth ConditionsHealth NewsNews & Discoveriespancreatic cancerThe Food and Drug AdministrationUSUS News
0 Comment
An approved cancer therapeutic, once used in only 1 percent of cancers, may have significant uses in the remaining 99 percent, according to a new study. “Ivosidenib, previously called AG-120, may be applicable to the large majority of cancers,” said senior author Dr. Jordan Winter, division chief of surgical oncology at University Hospitals Seidman Cancer Center in…
CDC Director Says Monkeypox Not Airborne
Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky says that the virus that causes Monkeypox is not airborne. “What I can say is that monkeypox is not thought to linger in the air as we think about the definition of airborne transmission,” Walensky told reporters in a briefing on June 10. “When we…
CDC Report Highlights Significant Link Between Substance Use and Psychiatric Disorders
June 11, 2022
admin
BrightCDC – U.S. Centers for Disease ControlhealthHealth Newsmental illnesspain relieverspsychiatric problemsSocial Issuessubstance abuseUSUS News
0 Comment
At least one-third of adults assessed for substance use at treatment centers in 2019 reported severe psychiatric problems, reveals the U.S. Centers for Disease Control and Prevention’s (CDC) most recent Morbidity and Mortality weekly report, published on June 10. According to the report, in 2019, 65.8 million adults reported engaging in binge drinking and 35.8…
Moderna’s COVID-19 Vaccine Effective in Toddlers, Babies: FDA
Moderna’s COVID-19 vaccine is effective for children as young as 6 months old, Food and Drug Administration (FDA) scientists said in a new analysis published late June 11. “Available data support the effectiveness of the Moderna COVID-19 Vaccine in preventing symptomatic COVID-19 in pediatric age groups from 6 months through 17 years of age,” the…
New Progress in Weight Loss: Scientists Discover Ways to Reduce Food Intake
June 11, 2022
admin
BrightChinafood intakehealthHealth NewsHK Current AffairsHong KongHong Kong Baptist Universityobesity
0 Comment
Obesity has become an increasingly serious global problem. Data show that since 1975, the number of obese people worldwide has increased twofold, and more and more people’s lives and health are affected by obesity. Researchers around the world have been trying to explore ways to lose weight. Some progresses have been made lately on how to…
Nanoparticle Cures Sepsis in Mice, Potentials for Future Treatment
The use of engineered nicotinamide adenine dinucleotide [NAD(H)], a molecule common to many animals, resulted in 100 percent sepsis survival in mice, creating a potential future treatment, a University of Wisconsin-Madison study has found. Researchers from the study say the NAD(H) nanoparticles also have the potential to treat many other diseases because NAD(H) is involved…
Median Drug Launch Price 85 Times Higher Compared to 2008
A study led by researchers from Brigham and Women’s Hospital has found that median launch prices for new drugs have grown 85 times higher compared to prices in 2008 in the United States, resulting in higher pharmaceutical expenditures for consumers. Median launch prices for new drugs have increased from costing $2,115 in 2008 to $180,000…
FDA Decision on Novavax COVID-19 Shot May Be Delayed
The Food and Drug Administration’s (FDA) decision to authorize the Novavax COVID-19 vaccine for emergency use may be delayed due to the FDA reviewing changes to the company’s manufacturing process. Novavax told The Epoch Times that the company updated the FDA on changes to its manufacturing process on June 3, days before the advisory committee…
FDA Decision on Novavax COVID-19 Shot May Be Delayed To Evaluate Changes in Manufacturing
The Food and Drug Administration’s (FDA) decision to authorize the Novavax COVID-19 vaccine for emergency use may be delayed due to the FDA reviewing changes to the company’s manufacturing process. Novavax told The Epoch Times that the company updated the FDA on changes to its manufacturing process on June 3, days before the advisory committee…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`